Financial Glossary and Balance Sheet Summary
P&L Below Operating Income
(Unit: \ millions)
FY2022
FY2023
Q1
Q2
Q3
Q4
Q1
Q2
Q3
Q4
Operating Income
¥38,520
¥22,684
¥31,524
¥10,968
¥56,275
¥27,614
¥46,310
¥4,546
1
Finance Income
23,308
31,844
30,312
5,590
14,075
16,763
13,204
7,108
Finance Costs 2
3,695
4,176
641
30,111
422
322
6,294
11,246
(Loss) reversal of loss on revaluation
3
339
(5,334)
487
(848)
2,719
463
(822)
3,893
Equity profit/(loss) of affiliates, equity
(1,271)
(1,555)
(5,822)
(1,598)
(744)
(1,691)
461
(1,536)
method companie
4
Impairment loss of investments
(44,425)
accounted for using equity method
Income/(loss) before Income Tax 4
57,201
43,463
55,860
(15,999)
71,903
42,827
52,859
(41,660)
Tax expense
17,082
17,280
14,743
(8,570)
18,637
18,372
17,374
462
Non-controlling interests
(142)
(289)
(80)
162
475
(83)
318
(235)
Net income/(loss) 4,5
40,261
26,472
41,197
(7,591)
52,791
24,538
35,167
(41,887)
1 Finance Income includes interest income primarily on cash deposits. 2022 Q1, Q2, Q3
and 2023 Q1, Q2, Q3 Finance Income includes FX conversion gains related to foreign
currency deposits and accounts receivable.
2 2022 and 2023 Q4 Finance Costs are primarily caused by FX conversion loss related to
foreign currency deposits and accounts receivable.
3 Loss/reversal of loss on revaluation refers to loss/reversal of loss on revaluation of cryptocurrency.
4 As a result of finalizing the provisional accounting treatment for a certain investment where the equity method is applied, "Equity
loss of affiliates, equity method companies" decreased by 1.8 billion yen in Q2 2022, increased by 2.1 billion yen in Q3 2022, and
decreased by 0.3 billion yen in Q4 2022. Consequently, "Income/(loss) before Income Tax" and "Net income (loss)" each increased
by 1.8 billion yen in Q2 2022, decreased by 2.1 billion yen in Q3 2022, and increased by 0.3 billion yen in Q4 2022. There is no financial
impact on the annual performance of 2022.
5 Net income/(loss) refers to net income/(loss) attributable to
owners of the parent.
© 2024 NEXON Co., Ltd. All Rights Reserved. 26View entire presentation